Research article
Baseline staging tests in primary breast cancer: a practice guideline
Robert E. Myers, Mary Johnston, Kathy Pritchard, Mark Levine, Tom Oliver and The Breast Cancer Disease Site Group of the Cancer Care Ontario Practice Guidelines Initiative
CMAJ May 15, 2001 164 (10) 1439-1444;
Robert E. Myers
From *the Department of Oncology, Credit Valley Hospital, Mississauga, Ont.; †the Program in Evidence-Based Care, Cancer Care Ontario, Hamilton, Ont.; ‡the Toronto–Sunnybrook Regional Cancer Centre, Toronto, Ont.; and §the Hamilton Regional Cancer Centre, Hamilton, Ont. R. Michael Crump, Toronto General Hospital, Toronto, Ont.; Catherine de Metz, Windsor Regional Cancer Centre, Windsor, Ont.; Dhali Dhaliwal, Northwestern Regional Cancer Centre, Thunder Bay, Ont.; Mary Sue Douglas, community representative; Nancy Down, North York General Hospital, Toronto, Ont.; David Ginsburg, Kingston Regional Cancer Centre, Kingston, Ont.; Ian Graham, Ottawa Hospital – Civic Campus, Ottawa, Ont.; Caroline Hamm, community physician, Wheatley, Ont.; Eric Holowaty, Ontario Cancer Registry, Toronto, Ont.; Barbara Lada, Northeastern Regional Cancer Centre, Sudbury, Ont.; E. Laukkanen, Windsor Regional Cancer Centre, Windsor, Ont.; Mark Levine, Hamilton Clinical Trials Research Institute, Hamilton, Ont.; David McCready, Princess Margaret Hospital, Toronto, Ont.; Douglas Mirsky, Ottawa Regional Women's Breast Centre, Ottawa, Ont.; Robert Myers, Credit Valley Hospital, Toronto, Ont.; Tom Oliver, Program in Evidence-Based Care, Cancer Care Ontario, Hamilton, Ont.; Frances O'Malley, Mount Sinai Hospital, Toronto, Ont.; Francisco Perera, London Regional Cancer Centre, London, Ont.; Kathleen Pritchard, chair, Toronto–Sunnybrook Regional Cancer Centre, Toronto, Ont.; Carol Sawka, Toronto–Sunnybrook Regional Cancer Centre, Toronto, Ont.; Marilyn Schneider, community representative; Wendy Shelley, Kingston Regional Cancer Centre, Kingston, Ont.; Eva Tomiak, Ottawa Regional Cancer Centre, Ottawa, Ont.; Shailendra Verma, Ottawa Regional Cancer Centre, Ottawa, Ont.; David Warr, Princess Margaret Hospital, Toronto, Ont.; and Tim Whelan, Hamilton Regional Cancer Centre, Hamilton, Ont.
Mary Johnston
From *the Department of Oncology, Credit Valley Hospital, Mississauga, Ont.; †the Program in Evidence-Based Care, Cancer Care Ontario, Hamilton, Ont.; ‡the Toronto–Sunnybrook Regional Cancer Centre, Toronto, Ont.; and §the Hamilton Regional Cancer Centre, Hamilton, Ont. R. Michael Crump, Toronto General Hospital, Toronto, Ont.; Catherine de Metz, Windsor Regional Cancer Centre, Windsor, Ont.; Dhali Dhaliwal, Northwestern Regional Cancer Centre, Thunder Bay, Ont.; Mary Sue Douglas, community representative; Nancy Down, North York General Hospital, Toronto, Ont.; David Ginsburg, Kingston Regional Cancer Centre, Kingston, Ont.; Ian Graham, Ottawa Hospital – Civic Campus, Ottawa, Ont.; Caroline Hamm, community physician, Wheatley, Ont.; Eric Holowaty, Ontario Cancer Registry, Toronto, Ont.; Barbara Lada, Northeastern Regional Cancer Centre, Sudbury, Ont.; E. Laukkanen, Windsor Regional Cancer Centre, Windsor, Ont.; Mark Levine, Hamilton Clinical Trials Research Institute, Hamilton, Ont.; David McCready, Princess Margaret Hospital, Toronto, Ont.; Douglas Mirsky, Ottawa Regional Women's Breast Centre, Ottawa, Ont.; Robert Myers, Credit Valley Hospital, Toronto, Ont.; Tom Oliver, Program in Evidence-Based Care, Cancer Care Ontario, Hamilton, Ont.; Frances O'Malley, Mount Sinai Hospital, Toronto, Ont.; Francisco Perera, London Regional Cancer Centre, London, Ont.; Kathleen Pritchard, chair, Toronto–Sunnybrook Regional Cancer Centre, Toronto, Ont.; Carol Sawka, Toronto–Sunnybrook Regional Cancer Centre, Toronto, Ont.; Marilyn Schneider, community representative; Wendy Shelley, Kingston Regional Cancer Centre, Kingston, Ont.; Eva Tomiak, Ottawa Regional Cancer Centre, Ottawa, Ont.; Shailendra Verma, Ottawa Regional Cancer Centre, Ottawa, Ont.; David Warr, Princess Margaret Hospital, Toronto, Ont.; and Tim Whelan, Hamilton Regional Cancer Centre, Hamilton, Ont.
Kathy Pritchard
From *the Department of Oncology, Credit Valley Hospital, Mississauga, Ont.; †the Program in Evidence-Based Care, Cancer Care Ontario, Hamilton, Ont.; ‡the Toronto–Sunnybrook Regional Cancer Centre, Toronto, Ont.; and §the Hamilton Regional Cancer Centre, Hamilton, Ont. R. Michael Crump, Toronto General Hospital, Toronto, Ont.; Catherine de Metz, Windsor Regional Cancer Centre, Windsor, Ont.; Dhali Dhaliwal, Northwestern Regional Cancer Centre, Thunder Bay, Ont.; Mary Sue Douglas, community representative; Nancy Down, North York General Hospital, Toronto, Ont.; David Ginsburg, Kingston Regional Cancer Centre, Kingston, Ont.; Ian Graham, Ottawa Hospital – Civic Campus, Ottawa, Ont.; Caroline Hamm, community physician, Wheatley, Ont.; Eric Holowaty, Ontario Cancer Registry, Toronto, Ont.; Barbara Lada, Northeastern Regional Cancer Centre, Sudbury, Ont.; E. Laukkanen, Windsor Regional Cancer Centre, Windsor, Ont.; Mark Levine, Hamilton Clinical Trials Research Institute, Hamilton, Ont.; David McCready, Princess Margaret Hospital, Toronto, Ont.; Douglas Mirsky, Ottawa Regional Women's Breast Centre, Ottawa, Ont.; Robert Myers, Credit Valley Hospital, Toronto, Ont.; Tom Oliver, Program in Evidence-Based Care, Cancer Care Ontario, Hamilton, Ont.; Frances O'Malley, Mount Sinai Hospital, Toronto, Ont.; Francisco Perera, London Regional Cancer Centre, London, Ont.; Kathleen Pritchard, chair, Toronto–Sunnybrook Regional Cancer Centre, Toronto, Ont.; Carol Sawka, Toronto–Sunnybrook Regional Cancer Centre, Toronto, Ont.; Marilyn Schneider, community representative; Wendy Shelley, Kingston Regional Cancer Centre, Kingston, Ont.; Eva Tomiak, Ottawa Regional Cancer Centre, Ottawa, Ont.; Shailendra Verma, Ottawa Regional Cancer Centre, Ottawa, Ont.; David Warr, Princess Margaret Hospital, Toronto, Ont.; and Tim Whelan, Hamilton Regional Cancer Centre, Hamilton, Ont.
Mark Levine
From *the Department of Oncology, Credit Valley Hospital, Mississauga, Ont.; †the Program in Evidence-Based Care, Cancer Care Ontario, Hamilton, Ont.; ‡the Toronto–Sunnybrook Regional Cancer Centre, Toronto, Ont.; and §the Hamilton Regional Cancer Centre, Hamilton, Ont. R. Michael Crump, Toronto General Hospital, Toronto, Ont.; Catherine de Metz, Windsor Regional Cancer Centre, Windsor, Ont.; Dhali Dhaliwal, Northwestern Regional Cancer Centre, Thunder Bay, Ont.; Mary Sue Douglas, community representative; Nancy Down, North York General Hospital, Toronto, Ont.; David Ginsburg, Kingston Regional Cancer Centre, Kingston, Ont.; Ian Graham, Ottawa Hospital – Civic Campus, Ottawa, Ont.; Caroline Hamm, community physician, Wheatley, Ont.; Eric Holowaty, Ontario Cancer Registry, Toronto, Ont.; Barbara Lada, Northeastern Regional Cancer Centre, Sudbury, Ont.; E. Laukkanen, Windsor Regional Cancer Centre, Windsor, Ont.; Mark Levine, Hamilton Clinical Trials Research Institute, Hamilton, Ont.; David McCready, Princess Margaret Hospital, Toronto, Ont.; Douglas Mirsky, Ottawa Regional Women's Breast Centre, Ottawa, Ont.; Robert Myers, Credit Valley Hospital, Toronto, Ont.; Tom Oliver, Program in Evidence-Based Care, Cancer Care Ontario, Hamilton, Ont.; Frances O'Malley, Mount Sinai Hospital, Toronto, Ont.; Francisco Perera, London Regional Cancer Centre, London, Ont.; Kathleen Pritchard, chair, Toronto–Sunnybrook Regional Cancer Centre, Toronto, Ont.; Carol Sawka, Toronto–Sunnybrook Regional Cancer Centre, Toronto, Ont.; Marilyn Schneider, community representative; Wendy Shelley, Kingston Regional Cancer Centre, Kingston, Ont.; Eva Tomiak, Ottawa Regional Cancer Centre, Ottawa, Ont.; Shailendra Verma, Ottawa Regional Cancer Centre, Ottawa, Ont.; David Warr, Princess Margaret Hospital, Toronto, Ont.; and Tim Whelan, Hamilton Regional Cancer Centre, Hamilton, Ont.
Tom Oliver
From *the Department of Oncology, Credit Valley Hospital, Mississauga, Ont.; †the Program in Evidence-Based Care, Cancer Care Ontario, Hamilton, Ont.; ‡the Toronto–Sunnybrook Regional Cancer Centre, Toronto, Ont.; and §the Hamilton Regional Cancer Centre, Hamilton, Ont. R. Michael Crump, Toronto General Hospital, Toronto, Ont.; Catherine de Metz, Windsor Regional Cancer Centre, Windsor, Ont.; Dhali Dhaliwal, Northwestern Regional Cancer Centre, Thunder Bay, Ont.; Mary Sue Douglas, community representative; Nancy Down, North York General Hospital, Toronto, Ont.; David Ginsburg, Kingston Regional Cancer Centre, Kingston, Ont.; Ian Graham, Ottawa Hospital – Civic Campus, Ottawa, Ont.; Caroline Hamm, community physician, Wheatley, Ont.; Eric Holowaty, Ontario Cancer Registry, Toronto, Ont.; Barbara Lada, Northeastern Regional Cancer Centre, Sudbury, Ont.; E. Laukkanen, Windsor Regional Cancer Centre, Windsor, Ont.; Mark Levine, Hamilton Clinical Trials Research Institute, Hamilton, Ont.; David McCready, Princess Margaret Hospital, Toronto, Ont.; Douglas Mirsky, Ottawa Regional Women's Breast Centre, Ottawa, Ont.; Robert Myers, Credit Valley Hospital, Toronto, Ont.; Tom Oliver, Program in Evidence-Based Care, Cancer Care Ontario, Hamilton, Ont.; Frances O'Malley, Mount Sinai Hospital, Toronto, Ont.; Francisco Perera, London Regional Cancer Centre, London, Ont.; Kathleen Pritchard, chair, Toronto–Sunnybrook Regional Cancer Centre, Toronto, Ont.; Carol Sawka, Toronto–Sunnybrook Regional Cancer Centre, Toronto, Ont.; Marilyn Schneider, community representative; Wendy Shelley, Kingston Regional Cancer Centre, Kingston, Ont.; Eva Tomiak, Ottawa Regional Cancer Centre, Ottawa, Ont.; Shailendra Verma, Ottawa Regional Cancer Centre, Ottawa, Ont.; David Warr, Princess Margaret Hospital, Toronto, Ont.; and Tim Whelan, Hamilton Regional Cancer Centre, Hamilton, Ont.
From *the Department of Oncology, Credit Valley Hospital, Mississauga, Ont.; †the Program in Evidence-Based Care, Cancer Care Ontario, Hamilton, Ont.; ‡the Toronto–Sunnybrook Regional Cancer Centre, Toronto, Ont.; and §the Hamilton Regional Cancer Centre, Hamilton, Ont. R. Michael Crump, Toronto General Hospital, Toronto, Ont.; Catherine de Metz, Windsor Regional Cancer Centre, Windsor, Ont.; Dhali Dhaliwal, Northwestern Regional Cancer Centre, Thunder Bay, Ont.; Mary Sue Douglas, community representative; Nancy Down, North York General Hospital, Toronto, Ont.; David Ginsburg, Kingston Regional Cancer Centre, Kingston, Ont.; Ian Graham, Ottawa Hospital – Civic Campus, Ottawa, Ont.; Caroline Hamm, community physician, Wheatley, Ont.; Eric Holowaty, Ontario Cancer Registry, Toronto, Ont.; Barbara Lada, Northeastern Regional Cancer Centre, Sudbury, Ont.; E. Laukkanen, Windsor Regional Cancer Centre, Windsor, Ont.; Mark Levine, Hamilton Clinical Trials Research Institute, Hamilton, Ont.; David McCready, Princess Margaret Hospital, Toronto, Ont.; Douglas Mirsky, Ottawa Regional Women's Breast Centre, Ottawa, Ont.; Robert Myers, Credit Valley Hospital, Toronto, Ont.; Tom Oliver, Program in Evidence-Based Care, Cancer Care Ontario, Hamilton, Ont.; Frances O'Malley, Mount Sinai Hospital, Toronto, Ont.; Francisco Perera, London Regional Cancer Centre, London, Ont.; Kathleen Pritchard, chair, Toronto–Sunnybrook Regional Cancer Centre, Toronto, Ont.; Carol Sawka, Toronto–Sunnybrook Regional Cancer Centre, Toronto, Ont.; Marilyn Schneider, community representative; Wendy Shelley, Kingston Regional Cancer Centre, Kingston, Ont.; Eva Tomiak, Ottawa Regional Cancer Centre, Ottawa, Ont.; Shailendra Verma, Ottawa Regional Cancer Centre, Ottawa, Ont.; David Warr, Princess Margaret Hospital, Toronto, Ont.; and Tim Whelan, Hamilton Regional Cancer Centre, Hamilton, Ont.
Article Figures & Tables
Tables
In this issue
Article tools
Respond to this article
Baseline staging tests in primary breast cancer: a practice guideline
Robert E. Myers, Mary Johnston, Kathy Pritchard, Mark Levine, Tom Oliver, The Breast Cancer Disease Site Group of the Cancer Care Ontario Practice Guidelines Initiative
CMAJ May 2001, 164 (10) 1439-1444;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Comparison of irregular flux viewer system with BONENAVI version for identification of Tc-99m MDP whole body bone scan metastasis images
- Unwarranted imaging for distant metastases in patients with newly diagnosed ductal carcinoma in situ and stage I and II breast cancer
- The Benefit of Baseline Staging-Risk Assessment of Distant Breast Cancer Metastases by Tumor Stage
- Imaging for distant metastases in women with early-stage breast cancer: a population-based cohort study
- Investigations for patients with early-stage breast cancer: oversetting the stage
- Use of Imaging for Staging of Early-Stage Breast Cancer in Two Integrated Health Care Systems: Adherence With a Choosing Wisely Recommendation
- Are Physicians Choosing Wisely When Imaging for Distant Metastases in Women With Operable Breast Cancer?
- Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial
- Initial Staging Impact of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Locally Advanced Breast Cancer
- Computer-Assisted Interpretation of Planar Whole-Body Bone Scans
- Is There a Role for Positron Emission Tomography in Breast Cancer Staging?
- Baseline staging tests for breast cancer
- Baseline staging tests in primary breast cancer